Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for disorders of the ...

A new study reveals that inhibitory neurons born later in development mature more quickly than earlier ones, allowing them to catch up and integrate evenly into neural networks.

The human brain is made up of billions of nerve cells (neurons) that communicate with each other in vast, interconnected ...

The study by Ozaita and colleagues in this issue identifies a function of CB1 cannabinoid receptors—THC-induced amnesia—and reveals the surprising role of GABAergic synapses in mediating this ...

Key takeawaysA new study that compares biological brains with artificial intelligence systems analyzed the neural network patterns that emerged during ...

A new preclinical study from scientists at Scripps Research suggests that an existing drug, already approved for treating ...

A study from the Max Planck Institute reveals that inhibitory neurons born later in development mature more rapidly to keep ...

This important study presents a new method for longitudinally tracking cells in two-photon imaging data that addresses the specific challenges of imaging neurons in the developing cortex. It provides ...

Excitatory neurons increase activity, while inhibitory neurons prevent cells from firing too much. • Published in Nature Neuroscience: A team at the Max Planck Institute for Biological Intelligence ...

Find the latest Relmada Therapeutics, Inc. (RLMD) stock quote, history, news and other vital information to help you with your stock trading and investing.

Effects on both the glutamatergic and GABAergic pathways in zebrafish were specific to the nanopesticide and differed from those in fish exposed to copper ions. Taken together, the Cu (OH) 2 ...